ebulisation of lyophilised platelet-rich plasma to improve compromised lung health in patients
- Conditions
- Health Condition 1: J418- Mixed simple and mucopurulent chronic bronchitis
- Registration Number
- CTRI/2024/08/072420
- Lead Sponsor
- Stem RX Hospital and Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Individuals who experience respiratory symptoms directly as a result
of COVID-19 infection.
- Patients with chest X-ray findings of peripheral ground glass opacities
seen in the lower lobe and/or consolidation
- Patients with fibrotic areas in the lung field on chest X-ray/CT scan
Six-minute walk test distance less than 300 m
- Individuals with associated systemic illnesses such as diabetes mellitus,
renal disease, hypertension, liver disease, pulmonary disorders, among
others
- Individuals who can give informed consent
1. Terminally ill COVID-19 patients/Patients not responding to conventional treatment/Patients with rapidly-progressing infection
2. Patients on OR those requiring ventilator support
3. Presence of active malignancy
4. Immunodeficient conditions
5. Hypercoagulation conditions
6. Any other associated medical condition requiring immediate attention
or uncontrolled status.
7. 10.Patients who have recently undergone organ transplantation, heartpacemaker
implantation (within 6 months)
8. Patients with other infectious/communicable disease.
9. Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method